FDA approves Gilead's Harvoni drug: Can we afford the $1125 once-a-day Hepatitis C pill?

October 11, 2014 10:55 AM

8 0

The Food and Drug Administration approved Gilead's Harvoni drug that aims to cure hepatitis C. It costs $94,500 over a 12-week program, equivalent to $1,125 daily.(Photo : Gilead Sciences)

The Food and Drug Administration approved Gilead's Harvoni drug that aims to cure hepatitis C. It costs $94,500 over a 12-week program, equivalent to $1,125 daily.

Read more

To category page

Loading...